Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05698212
PHASE2

Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers

Sponsor: Hera Biotech, Inc.

View on ClinicalTrials.gov

Summary

This study is testing a way to diagnose endometriosis using a uterine tissue biopsy (similar to a pap smear) as opposed to undergoing laparoscopy surgery. The tissue is sent to lab for cellular analysis with a proprietary AI (artificial intelligence) technology.

Official title: Proof-of-Concept, Obs Study to Evaluate Accuracy of MetriDx Lab Developed Test (LDT) to Accurately Identify Endometriosis-specific Biological Markers Using Micro-fluidic Analysis of Cells Enabling Clinicians to Diagnose Endometriosis

Key Details

Gender

FEMALE

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

75

Start Date

2022-09-14

Completion Date

2023-04-10

Last Updated

2023-01-26

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

MetriDx

Biopsied tissue will be analyze by proprietary LDT, MetriDx, and compared to laparoscopy diagnostic report on record

Locations (3)

Valley OB-GYN Clinic, PC

Saginaw, Michigan, United States

Corpus Christi Women's Center

Corpus Christi, Texas, United States

University of Texas Physician's Women's Center--Memorial City

Houston, Texas, United States